Because PLI Managementhas let us get to this point, I'm beginning to think even with FDA granting priority review, it won't help. I think it's too far gone. Anyway, how good is a late priority review... Maybe a pediatric voucher is our only hope of restoring the share price. I continue to be incredulous that PLI management continues to think they can dish out a bit of fluff to stablize the market. That they didn't anticipate a backlash leaves me underwhelmed. I'm still long but not strong.